Orange Book Companion: Difference between revisions
| Line 10: | Line 10: | ||
*[http://www.orangebookcompanion.com/description.htm Why Subscribe to The Orange Book Companion] | *[http://www.orangebookcompanion.com/description.htm Why Subscribe to The Orange Book Companion] | ||
*[http://www.orangebookcompanion.com/Bruce_Pokras_Conference_Presentations.htm Bruce Pokras' Presentation History] | *[http://www.orangebookcompanion.com/Bruce_Pokras_Conference_Presentations.htm Bruce Pokras' Presentation History] | ||
*[http://www.orangebookinsights.com/ Bruce's | *[http://www.orangebookinsights.com/ Bruce's Insights: A Comment Blog] | ||
== See Also == | == See Also == | ||
Revision as of 18:05, 30 December 2018
http://www.orangebookcompanion.com
Free and paid information about patents covering FDA-approved drugs
Enchanced FDA "Orange Book" patent and exclusivity information for FDA-approved drugs created by a Philly native.
- Drug Patent Expirations, Patent Titles, Claim Types, Drug Classes, Hyperlinks to the patents and FDA Info, and much more.
- Historical Orange Book patent and exclusivity info back to the dawn of the Hatch-Waxman Act in 1984.
Info
- Why Subscribe to The Orange Book Companion
- Bruce Pokras' Presentation History
- Bruce's Insights: A Comment Blog